CDKN2A and gliosarcoma: Similar to IDH-wildtype GBM, gliosarcomas contain PTEN, CDKN2A and TP53 alterations, but amplification of the EGFR (epidermal growth factor receptor) are uncommon (4–8%) [7–9].